Ferrara, Roberto
Ferrara, Roberto
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that?
2016-01-01 Ferrara, Roberto; Caccese, Mario; Cuppone, Federica; Bria, Emilio; Tortora, Giampaolo; Pilotto, Sara
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer
2015-01-01 Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice
2016-01-01 Caccese, M; Ferrara, R; Pilotto, S; Carbognin, L; Grizzi, G; Caliò, A; Brunelli, M; Cuppone, F; Petraglia, S; Scarpa, A; Tortora, G; Bria, E
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives
2015-01-01 Calvetti, Lorenzo; Pilotto, Sara; Carbognin, Luisa; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio
Tubulin inhibitors in non-small cell lung cancer: looking back and forward
2016-01-01 Ferrara, Roberto; Pilotto, Sara; Peretti, Umberto; Caccese, Mario; Kinspergher, Stefania; Carbognin, Luisa; Karachaliou, N; Rosell, R; Tortora, Giampaolo; Bria, Emilio
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Adjuvant therapy for resected early-stage small-cell lung cancer: is now time to rethink about that? | 1-gen-2016 | Ferrara, Roberto; Caccese, Mario; Cuppone, Federica; Bria, Emilio; Tortora, Giampaolo; Pilotto, Sara | |
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancer | 1-gen-2015 | Pilotto, Sara; Novello, Silvia; Peretti, Umberto; Kinspergher, Stefania; Ciuffreda, Ludovica; Milella, Michele; Carbognin, Luisa; Vavalà, Tiziana; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio | |
Current and developing therapies for the treatment of non-small cell lung cancer with ALK abnormalities: update and perspectives for clinical practice | 1-gen-2016 | Caccese, M; Ferrara, R; Pilotto, S; Carbognin, L; Grizzi, G; Caliò, A; Brunelli, M; Cuppone, F; Petraglia, S; Scarpa, A; Tortora, G; Bria, E | |
The coming of ramucirumab in the landscape of anti-angiogenic drugs: potential clinical and translational perspectives | 1-gen-2015 | Calvetti, Lorenzo; Pilotto, Sara; Carbognin, Luisa; Ferrara, Roberto; Caccese, Mario; Tortora, Giampaolo; Bria, Emilio | |
Tubulin inhibitors in non-small cell lung cancer: looking back and forward | 1-gen-2016 | Ferrara, Roberto; Pilotto, Sara; Peretti, Umberto; Caccese, Mario; Kinspergher, Stefania; Carbognin, Luisa; Karachaliou, N; Rosell, R; Tortora, Giampaolo; Bria, Emilio |